Coldstream Capital Management Inc Immunity Bio, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 84 shares of IBRX stock, worth $176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$176% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
240Shares Held
87.5MCall Options Held
974KPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA20.3MShares$42.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$24 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$20.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$9.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$8.41 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $841M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...